Dr. Vaithilingaraja Arumugaswami (left) and Dr. Song Li (right), UCLA Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two additional projects as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of projects CIRM is supporting to 11, including two clinical trials. The Board awarded $349,999 … Continue reading CIRM Board Approves Two Additional COVID-19 Projects
Translational research
CIRM Board Approves $19.7 Million in Awards for Translational Research Program
In addition to approving funding for breast cancer related brain metastases last week, the CIRM Board also approved an additional $19.7 million geared towards our translational research program. The goal of this program is to help promising projects complete the testing needed to begin talking to the US Food and Drug Administration (FDA) about holding … Continue reading CIRM Board Approves $19.7 Million in Awards for Translational Research Program
Stem cell byproducts provide insight into cure for spina bifida
A diagram of an infant born with spina bifida, a birth defect where there is an incomplete closing of the backbone portion of the spinal cord. Photo courtesy of the Texas Children's Hospital website. Some of you might remember a movie in the early 2000s by the name of "Miracle in Lane 2". The film … Continue reading Stem cell byproducts provide insight into cure for spina bifida
Performance, Passion and Progress: and that’s just page one of our 2018 Annual Report
It’s hard to sum up the activities and achievements of a year in a single document, let alone one that’s just 24 pages. But that’s what we have done in putting together our 2018 Annual Report. It’s a look back at the year just gone, the highlights, the low lights (spoiler alert – there weren’t … Continue reading Performance, Passion and Progress: and that’s just page one of our 2018 Annual Report
Scientists say they’re one step closer to being able to build a new you, using your own stem cells.
One of the biggest obstacles to transplanting organs from one person to another is that the immune system of the person getting the new life-saving organ often tries to reject it. The immune cells see the new material as “foreign” and attacks it, sometimes destroying it. Right now, the only way to prevent that is … Continue reading Scientists say they’re one step closer to being able to build a new you, using your own stem cells.
New hope for stem cell therapy in patients with leukemia
Of the many different kinds of cancer that affect humans, leukemia is the most common in young people. As with many types cancer, doctors mostly turn to chemotherapy to treat patients. Chemotherapy, however, comes with its own share of issues, primarily severe side effects and the constant threat of disease recurrence. Stem cell therapy treatment … Continue reading New hope for stem cell therapy in patients with leukemia
CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is pretty grim, only between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that … Continue reading CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
Say Hello to CIRM’s New Active Awards Portfolio Dashboard (Video Included!)
It takes a lot of time, money and effort to develop a promising stem cell research idea into an effective treatment that can help patients. Oftentimes, you don’t hear about the early-stage research that goes into developing a particular treatment until it reaches the clinic. CIRM recognizes the importance of investing in all stages of … Continue reading Say Hello to CIRM’s New Active Awards Portfolio Dashboard (Video Included!)
Harnessing the body’s immune system to tackle cancer
Often on the Stem Cellar we write about work that is in a clinical trial. But getting research to that stage takes years and years of dedicated work. Over the next few months, we are profiling some of the scientists we fund who are doing Discovery (early stage) and Translational (pre-clinical) research, to highlight the … Continue reading Harnessing the body’s immune system to tackle cancer
Budgeting for the future of the stem cell agency
Budgets are very rarely exciting things; but they are important. For example, it’s useful for a family to know when they go shopping exactly how much money they have so they know how much they can afford to spend. Stem cell agencies face the same constraints; you can’t spend more than you have. Last week … Continue reading Budgeting for the future of the stem cell agency
The Stem Cellar 